Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.02
-0.17 (-5.33%)
At close: Aug 15, 2025, 3:00 PM
Protara Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 332K | n/a | n/a | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 98K | 83K | n/a | 84K | 83K | 83K | 107K | 107K | 420K | 77K | 74K | 64K | 395K | 397K | n/a | n/a | 55K | 32K |
Gross Profit | -98K | -83K | 166K | -84K | -83K | -83K | 1.1M | -107K | -420K | -77K | -74K | -64K | -395K | -397K | n/a | n/a | -55K | -32K |
Operating Income | -16.59M | -14.12M | -14.31M | -12.33M | -10.66M | -11.85M | -11.04M | -10.7M | -12.14M | -9.73M | 20.47M | -7.97M | -8.71M | -10.87M | -10.29M | -10.83M | -12.79M | -13.58M |
Interest Income | 1.61M | 1.72M | 1.15M | 1.1M | 1.14M | 747K | 814K | 840K | 842K | 687K | 632K | 557K | 512K | 529K | 1.8M | 547K | 513K | 397K |
Pretax Income | -14.96M | -11.91M | -12.77M | -11.22M | -9.51M | -11.1M | -10.22M | -9.86M | -11.29M | -9.04M | -38.97M | -7.69M | -8.54M | -10.76M | -10.23M | -10.78M | -12.78M | -13.46M |
Net Income | -14.96M | -11.91M | -12.77M | -11.22M | -9.51M | -11.1M | -10.22M | -9.86M | -11.29M | -8.36M | -38.86M | -7.41M | -8.19M | -10.64M | -10.23M | -10.78M | -12.78M | -13.46M |
Selling & General & Admin | 5.82M | 4.98M | 4.81M | 4.26M | 4.27M | 4.1M | 4.55M | 4.48M | 4.89M | 4.59M | 5M | 4.51M | 5.62M | 5.61M | 6.22M | 6.74M | 6.91M | 6.54M |
Research & Development | 10.77M | 9.15M | 9.5M | 8.07M | 6.39M | 7.67M | 6.38M | 6.22M | 7.25M | 5.14M | 4.99M | 3.47M | 3.08M | 5.27M | 4.07M | 4.09M | 5.89M | 7.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.59M | 14.12M | 14.31M | 12.33M | 10.66M | 11.77M | 11.04M | 10.7M | 12.14M | 9.73M | 9.99M | 7.97M | 8.71M | 10.87M | 10.29M | 10.83M | 12.79M | 13.58M |
Interest Expense | 1.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 107K | 274K | 346K | 410K | n/a | 494K | 503K | 282K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.59M | 14.12M | 14.31M | 12.33M | 10.66M | 11.85M | 11.04M | 10.7M | 12.14M | 9.73M | 9.99M | 7.97M | 8.71M | 10.87M | 10.29M | 10.83M | 12.79M | 13.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -687K | -107K | -283K | -346K | -119K | n/a | 24K | n/a | n/a |
Shares Outstanding (Basic) | 42.27M | 40.71M | 26.43M | 22.33M | 21.23M | 11.42M | 11.36M | 11.35M | 11.31M | 11.3M | 11.27M | 11.27M | 11.26M | 11.25M | 11.24M | 11.24M | 11.23M | 11.23M |
Shares Outstanding (Diluted) | 42.27M | 40.71M | 26.43M | 22.33M | 21.23M | 11.42M | 11.36M | 11.35M | 11.31M | 11.3M | 11.27M | 11.27M | 11.26M | 11.25M | 11.24M | 11.24M | 11.23M | 11.23M |
EPS (Basic) | -0.35 | -0.29 | -0.48 | -0.5 | -0.45 | -0.97 | -0.9 | -0.87 | -1 | -0.74 | -3.45 | -0.66 | -0.73 | -0.95 | -0.91 | -0.96 | -1.14 | -1.2 |
EPS (Diluted) | -0.35 | -0.29 | -0.48 | -0.5 | -0.45 | -0.97 | -0.9 | -0.87 | -1 | -0.74 | -3.45 | -0.66 | -0.73 | -0.95 | -0.91 | -0.96 | -1.14 | -1.2 |
EBITDA | -16.59M | -14.12M | -14.23M | -12.25M | -10.58M | -11.77M | -10.93M | -10.62M | -12.06M | -9.65M | -38.79M | -7.35M | -7.8M | -10.36M | -10.23M | -10.78M | -12.73M | -13.43M |
EBIT | -14.96M | -11.91M | -14.31M | -12.33M | -10.66M | -11.85M | -11.04M | -10.7M | -12.14M | -9.73M | -38.86M | -7.42M | -8.19M | -10.35M | -10.23M | -10.28M | -12.28M | -13.46M |
Depreciation & Amortization | n/a | 83K | 82K | 84K | 83K | 83K | 107K | 107K | 420K | 77K | 74K | 64K | 395K | 397K | 54K | 688K | 55K | 32K |